From fruit fly to bedside
Authors:
- Lisa M. ShulmanLSLisa M. Shulman
- William J. WeinerWWWilliam J. Weiner
- Mel B. FeanyMFMel B. Feany
- 1 August 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 16 (4) , 443-449
Abstract
Fly models have been developed for a variety of neurodegenerative disorders, and the field is beginning to harness the power of Drosophila genetics to dissect pathways of disease pathogenesis and identify targets for therapeutic intervention. In this review, we emphasize the most recent accomplishments and chart the potential rewards in translating lessons from Drosophila models to clinical therapeutics. The conservation of human disease genes in the Drosophila genome forms the basis for several recent investigations of the normal biological functions of genes implicated in neurodegenerative disease. In addition, transgenic approaches continue to expand the list of diseases modeled in Drosophila that now includes Parkinson's disease, Alzheimer's disease, Huntington's disease, and several spinocerebellar ataxias. Studies based on these models suggest that protein folding and degradation pathways play an important role in Parkinson's disease and the polyglutamine repeat disorders, and that kinases and apoptotic pathways may modulate neurodegeneration in tauopathies. Ongoing genetic studies with Drosophila neurodegenerative disease models promise to enhance our understanding of disease pathogenesis and generate target lists for future investigational research and drug development. The next challenge will be distilling a growing number of possible targets into a shortlist for fast-track drug design and clinical trials. With the advent of neurodegenerative disease models, the fruit fly is rapidly assuming a unique niche in bench to bedside research.Keywords
This publication has 39 references indexed in Scilit:
- A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in DrosophilaNature Genetics, 2002
- Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's DiseaseScience, 2002
- Nicastrin is required for Presenilin-mediated transmembrane cleavage in DrosophilaNature Cell Biology, 2001
- Disruption of Axonal Transport and Neuronal Viability by Amyloid Precursor Protein Mutations in DrosophilaNeuron, 2001
- Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary TanglesScience, 2001
- Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic MiceJournal of Biological Chemistry, 2000
- Genetic Suppression of Polyglutamine Toxicity in DrosophilaScience, 2000
- A Drosophila model of Parkinson's diseaseNature, 2000
- Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in DrosophilaHuman Molecular Genetics, 2000
- Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for appl geneNeuron, 1992